Skip to main content
Fig. 1 | Molecular Cancer

Fig. 1

From: LncRNA MIR31HG targets HIF1A and P21 to facilitate head and neck cancer cell proliferation and tumorigenesis by promoting cell-cycle progression

Fig. 1

Overexpression of MIR31HG or co-expression of HIF1A-positive and p21-negative served as a poor prognostic factor for LSCC patients. a Patients in the MIR31HG high-expression group (n = 30) had a significantly worse overall survival and recurrence free survival than patients in the MIR31HG low-expression group (n = 30). P < 0.05, log-rank test. b Patients in the HIF1A high-expression group (n = 30) had a worse overall survival and recurrence free survival than patients in the HIF1A low-expression group (n = 30). P > 0.05, log-rank test. c Patients were stratified into four groups based on the expression of HIF1A and p21, patients with HIF1A-positive and p21-negative expression had a significantly worse overall survival and recurrence free survival than other groups. P < 0.05, log-rank test

Back to article page

Molecular Cancer

ISSN: 1476-4598